mesoestetic Pharma Group

Background

Founded in 1984, mesoestetic Pharma Group is a multinational pharmaceutical company specializing in the development, manufacturing, and marketing of topical drugs, medical devices, medical-aesthetic equipment, cosmeceuticals, and nutraceuticals. The company's mission is to provide innovative and efficient solutions for skin treatment and care, with a strong emphasis on research and development. Headquartered in Viladecans, Catalonia, Spain, mesoestetic has established itself as a leader in dermatology and aesthetic medicine, offering a comprehensive range of products characterized by high innovation and significant scientific contribution.

Key Strategic Focus

mesoestetic's strategic focus centers on delivering integral aesthetic solutions through continuous innovation and adherence to strict pharmaceutical standards. The company specializes in:

Depigmentation Treatments: Recognized globally for products like cosmelan®, a leading treatment for hyperpigmentation.

Anti-Aging Solutions: Offering customizable anti-aging treatments, including the mesohyal® range of injectable medical devices with CE marking for intradermal aesthetic injections.

Medical-Aesthetic Equipment: Developing devices such as Genesis, which integrates multiple technologies for personalized treatments.

The company targets both professional and consumer markets, providing products for in-clinic procedures and at-home care, thereby addressing a broad spectrum of skin health needs.

Financials and Funding

As of 2022, mesoestetic reported its best economic results in history, with a 35% growth compared to the previous year, reaching a turnover of €6.9 million, up from €5.8 million in 2021. The company's net profit accumulated to €14.5 million. Notably, mesoestetic reinvests 40% of its annual profits into research and development, underscoring its commitment to innovation.

Pipeline Development

mesoestetic's product pipeline includes:

Depigmentation Treatments: The company has been a world leader in treating hyperpigmentation, notably with the launch of cosmelan®.

Anti-Aging Solutions: The mesohyal® range offers customizable anti-aging treatments through injectable medical devices.

Medical-Aesthetic Equipment: Genesis, a device integrating multiple technologies for personalized treatments, exemplifies mesoestetic's innovation in medical-aesthetic equipment.

Technological Platform and Innovation

mesoestetic distinguishes itself through several proprietary technologies and scientific methodologies:

Biotechnology Unit: Established to perform tests in cell cultures using molecular biology techniques, focusing on aging and depigmentation research.

SmartDrivity® Technology: Integrated into devices like Genesis, combining multiple technologies for customized treatments.

[meso]epigen system™: A patented complex based on epigenetics, developed in collaboration with the Josep Carreras Institute, aimed at reversing aging markers.

Leadership Team

Joan Carles Font: Founder and CEO, instrumental in establishing mesoestetic's commitment to research and innovation.

Carles Font: Director of Business Development and Foreign Trade, focusing on international expansion and strategic partnerships.

David Cañas: Director of Control and Organizational Management and Development, overseeing financial health and operational efficiency.

Xavier Font: Director of Legal and Compliance Area, ensuring adherence to regulatory standards and legal frameworks.

Competitor Profile

Market Insights and Dynamics

The global dermatology and aesthetic medicine market is experiencing significant growth, driven by increasing consumer awareness and demand for non-invasive treatments. mesoestetic's focus on innovation positions it well within this expanding market.

Competitor Analysis

Key competitors include:

Insud Pharma: Engaged in research, development, manufacturing, and marketing of active pharmaceutical ingredients and finished dosage forms.

Sandoz: Specializes in generic and biosimilar medicines.

JBCPL (JB Chemicals and Pharmaceuticals): A pharmaceutical company with a diverse product portfolio.

Joincare: Manufactures and supplies pharmaceutical products.

Strategic Collaborations and Partnerships

mesoestetic collaborates with research centers, universities, and scientific groups to stay at the forefront of cosmetic science advancements. These partnerships enhance the company's research capabilities and contribute to the development of innovative products.

Operational Insights

Strategically, mesoestetic emphasizes:

International Expansion: With products available in over 90 countries and subsidiaries in Poland and plans for Dubai, the company aims to strengthen its global presence.

Sustainability Initiatives: Investments in photovoltaic plants and energy-efficient technologies reflect a commitment to environmental responsibility.